Literature DB >> 28295435

The role of thyroid hormones in acute coronary syndromes: Prognostic value of alterations in thyroid hormones.

Vasileios Lamprou1, Dimitrios Varvarousis2, Kali Polytarchou3, Giolanda Varvarousi4, Theodoros Xanthos1,5.   

Abstract

The prognosis of acute coronary syndromes (ACS) is affected by many factors. Normal thyroid homeostasis is known to alter during various critical illnesses, a condition that has been shown to correlate with the severity of the disease and increased mortality. The purpose of this article is to review literature to emphasize the considerable association of thyroid function with the cardiovascular system and summarize all existing evidence with regard to the role of thyroid hormones alterations during ACS. The electronic databases of PubMed, Medline, Scopus, and Cochrane were searched for relevant literature and studies. Alterations in thyroid hormone plasma concentrations, especially low triiodothyronine (T3) levels, represent a hormonal imbalance that is not uncommon among patients suffering an acute coronary event. Many studies have identified this abnormal thyroid hormonal status to be related to worse prognosis. Although further large-scale clinical trials are needed, the low T3 syndrome manifesting in patients during ACS might be useful in prognostic stratification.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Acute Coronary Syndromes; Low T3 Syndrome; Myocardial Ischemia; Prognosis; Thyroid Hormones

Mesh:

Substances:

Year:  2017        PMID: 28295435      PMCID: PMC6490650          DOI: 10.1002/clc.22689

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  40 in total

1.  Euthyroid sick syndrome in acute ischemic syndromes.

Authors:  H N Pavlou; P A Kliridis; A A Panagiotopoulos; C P Goritsas; P J Vassilakos
Journal:  Angiology       Date:  2002 Nov-Dec       Impact factor: 3.619

Review 2.  Thyroid hormone action in the heart.

Authors:  George J Kahaly; Wolfgang H Dillmann
Journal:  Endocr Rev       Date:  2005-01-04       Impact factor: 19.871

3.  Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction.

Authors:  L Friberg; V Drvota; A H Bjelak; G Eggertsen; S Ahnve
Journal:  Am J Med       Date:  2001-12-15       Impact factor: 4.965

4.  Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction.

Authors:  T Kimura; T Kanda; N Kotajima; A Kuwabara; Y Fukumura; I Kobayashi
Journal:  Eur J Endocrinol       Date:  2000-08       Impact factor: 6.664

5.  Nongenomic cardiovascular effects of triiodothyronine in euthyroid male volunteers.

Authors:  Bernhard M W Schmidt; Nicole Martin; Anette C Georgens; Hanns-C Tillmann; Martin Feuring; Michael Christ; Martin Wehling
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

Review 6.  Nongenomic actions of thyroid hormone on the heart.

Authors:  Paul J Davis; Faith B Davis
Journal:  Thyroid       Date:  2002-06       Impact factor: 6.568

7.  Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease.

Authors:  Giorgio Iervasi; Alessandro Pingitore; Patrizia Landi; Mauro Raciti; Andrea Ripoli; Maria Scarlattini; Antonio L'Abbate; Luigi Donato
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

8.  Endocrine measurements in survivors and non-survivors from critical illness.

Authors:  David C Ray; Andrew Macduff; Gordon B Drummond; Ewan Wilkinson; Bill Adams; Geoff J Beckett
Journal:  Intensive Care Med       Date:  2002-08-09       Impact factor: 17.440

9.  Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina?

Authors:  Leif Friberg; Sigbritt Werner; Gösta Eggertsen; Staffan Ahnve
Journal:  Arch Intern Med       Date:  2002-06-24

10.  Clinical investigation: thyroid function test abnormalities in cardiac arrest associated with acute coronary syndrome.

Authors:  Kenan Iltumur; Gonul Olmez; Zuhal Ariturk; Tuncay Taskesen; Nizamettin Toprak
Journal:  Crit Care       Date:  2005-06-09       Impact factor: 9.097

View more
  11 in total

1.  Thyroid stimulating hormone elevation as a predictor of long-term mortality in patients with acute myocardial infarction.

Authors:  Suk Min Seo; Yoon-Seok Koh; Hun-Jun Park; Dong Bin Kim; Sung Ho Her; Jong Min Lee; Chul Soo Park; Pum-Joon Kim; Hee Yeol Kim; Ki Dong Yoo; Doo Soo Jeon; Young Keun Ahn; Myung Ho Jeong; Wook Sung Chung; Ki-Bae Seung
Journal:  Clin Cardiol       Date:  2018-10-16       Impact factor: 2.882

2.  Impact of low triiodothyronine syndrome on long-term outcomes in patients with myocardial infarction with nonobstructive coronary arteries.

Authors:  Side Gao; Wenjian Ma; Sizhuang Huang; Xuze Lin; Mengyue Yu
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

3.  Association between Low Free Triiodothyronine Levels and Poor Prognosis in Patients with Acute ST-Elevation Myocardial Infarction.

Authors:  Yuanbin Song; Jiabei Li; Shizhu Bian; Zhexue Qin; Yaoming Song; Jun Jin; Xiaohui Zhao; Mingbao Song; Jianfei Chen; Lan Huang
Journal:  Biomed Res Int       Date:  2018-04-16       Impact factor: 3.411

Review 4.  The impact of thyroid hormone dysfunction on ischemic heart disease.

Authors:  Madalena von Hafe; João Sergio Neves; Catarina Vale; Marta Borges-Canha; Adelino Leite-Moreira
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

Review 5.  The Role of Thyroid Diseases and their Medications in Cardiovascular Disorders: A Review of the Literature.

Authors:  Negar Omidi; Mohammadrafie Khorgami; Farbod Z Tajrishi; Amirhosein Seyedhoseinpour; Parichehr Pasbakhsh
Journal:  Curr Cardiol Rev       Date:  2020

6.  Prognostic value of free triiodothyronine and N-terminal pro-B-type natriuretic peptide for patients with acute myocardial infarction undergoing percutaneous coronary intervention: a prospective cohort study.

Authors:  Kaihao Wang; Wenyao Wang; Kuo Zhang; Jun Gao; Yupeng Liu; Jilin Zheng; Ping Li; Yida Tang
Journal:  Ann Transl Med       Date:  2021-02

Review 7.  Prognostic implications of thyroid hormone alterations in acute coronary syndrome-A systematic review.

Authors:  Priyadarshini Arambam; Upendra Kaul; Priya Ranjan; Rajiv Janardhanan
Journal:  Indian Heart J       Date:  2020-11-23

8.  Serum total triiodothyronine (T3) as a predictor of mortality and morbidity in critically ill patients and its correlation of predictability with acute physiology and chronic health evaluation II score: A prospective observational study.

Authors:  M R Thilak; Seema M Shetty; Chitra M Kotian; Afsal P Mohammed; Pushwinder Dhunputh; Shashikiran Umakanth; Pallavi P Saraswat
Journal:  Int J Crit Illn Inj Sci       Date:  2021-06-29

9.  Predictive Value of Free Triiodothyronine to Free Thyroxine Ratio in Euthyroid Patients With Myocardial Infarction With Nonobstructive Coronary Arteries.

Authors:  Side Gao; Wenjian Ma; Sizhuang Huang; Xuze Lin; Mengyue Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-28       Impact factor: 5.555

10.  Free triiodothyronine and global registry of acute coronary events risk score on predicting long-term major adverse cardiac events in STEMI patients undergoing primary PCI.

Authors:  Xuewei Chang; Shouyan Zhang; Mingming Zhang; Hao Wang; Caifeng Fan; Yunfei Gu; Jinghan Wei; Chunguang Qiu
Journal:  Lipids Health Dis       Date:  2018-10-12       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.